Citrus nobiletin suppresses bone loss in ovariectomized ddY mice and collagen-induced arthritis in DBA/1J mice: Possible involvement of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis regulation

BioFactors

Volumn 30, Issue 3, 2007, Pages 179-192

  Murakami, Akira ^a   Song, Meiyu ^a   Katsumata, Shin Ichi ^b   Uehara, Mariko ^b   Suzuki, Kazuharu ^b   Ohigashi, Hajime ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^c FUKUI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

MAP kinase; Nobiletin; Osteoclastogenesis; Osteoporosis; RAW264.7 cells; Rheumatoid arthritis

Indexed keywords

1' ACETOXYCHAVICOL ACETATE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; AURAPTENE; COLLAGEN; COLLAGEN TYPE 2; ESTRADIOL; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; NOBILETIN; OSTEOCLAST DIFFERENTIATION FACTOR; PHENETHYL ISOTHIOCYANATE; PLANT MEDICINAL PRODUCT; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; ZERUMBONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BONE DENSITY; CITRUS FRUIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DBA 1 MOUSE; DRUG EFFICACY; DRUG INHIBITION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; MALE; MICROSCOPY; MOUSE; NONHUMAN; OSMOTIC PUMP; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TREATMENT PLANNING; VEGETABLE;

ANIMALS; ANTIOXIDANTS; ARTHRITIS, EXPERIMENTAL; BLOTTING, WESTERN; BONE DENSITY; BONE RESORPTION; CELL LINE; CITRUS; COUMARINS; FEMALE; FLAVONES; ISOTHIOCYANATES; MICE; MICE, INBRED DBA; MOLECULAR STRUCTURE; OSTEOGENESIS; OVARIECTOMY; RANK LIGAND; SESQUITERPENES; TERPENES;

ANIMALIA; CITRUS; MUS;

EID: 47849089229     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520300305     Document Type: Article

References (57)

1. H.S. Baraf, Efficacy of the newest COX-2 selective inhibitors in rheumatic disease, Curr Pharm Des 13 (2007), 2228-2236.
2. M.A. Brown, Antibody treatments of inflammatory arthritis, Curr Med Chem 12 (2005), 2943-2946.
3. E. Canalis, A. Giustina and J.P. Bilezikian, Mechanisms of anabolic therapies for osteoporosis, N Engl J Med 357 (2007), 905-916.
4. H. Chiba, M. Uehara, J. Wu, X. Wang, R. Masuyama, K. Suzuki, K. Kanazawa and Y. Ishimi, Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice, J Nutr 133 (2003), 1892-1897.
5. H.H. Chow, D. Salazar and I.A. Hakim, Pharmacokinetics of perillic acid in humans after a single dose administration of a citrus preparation rich in d-limonene content, Cancer Epidemiol Biomarkers Prev 11 (2002), 1472-1476.
6. P. Efthimiou, A. Kontzias, C.M. Ward and N.S. Ogden, Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol 3 (2007), 328-335.
7. A. Eguchi, A. Murakami and H. Ohigashi, Nobiletin, a citrus flavonoid, suppresses phorbol ester-induced expression of multiple scavenger receptor genes in THP-1 human monocytic cells, FEBS Lett 580 (2006), 3321-3328.
8. M. Fujioka, M. Uehara, J. Wu, H. Adlercreutz, K. Suzuki, K. Kanazawa, K. Takeda, K. Yamada and Y. Ishimi, Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice, J Nutr 134 (2004), 2623-2627.
9. N. Giuliani, S. Colla and V. Rizzoli, New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL), Exp Hematol 32 (2004), 685-691.
10. K. Hayashi, R. Suzuki, S. Miyamoto, Y. Shin-Ichiroh, H. Kohno, S. Sugie, S. Takashima and T. Tanaka, Citrus Auraptene Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in C57BL/KsJ-db/db Mice, Nutr Cancer 58 (2007), 75-84.
11. S.C. Ho, J. Woo, S. Lam, Y. Chen, A. Sham and J. Lau, Soy protein consumption and bone mass in early postmenopausal Chinese women, Osteoporos Int 14 (2003), 835-842.
12. L.C. Hofbauer and M. Schoppet, Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases, JAMA 292 (2004), 490-495.
13. H. Ishida, T. Uesugi, K. Hirai, T. Toda, H. Nukaya, K. Yokotsuka and K. Tsuji, Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet, Biol Pharm Bull 21 (1998), 62-66.
14. J. Ishiwa, T. Sato, Y. Mimaki, Y. Sashida, M. Yano and A. Ito, A citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts, J Rheumatol 27 (2007), 20-25.
15. C. Kandaswami, E. Perkins, D.S. Soloniuk, G. Drzewiecki and E. Middleton Jr., Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro, Cancer Lett 56 (1991), 147-152.
16. J.S. Kang,, Y.D. Yoon, M.H. Han, S.B. Han, K. Lee, M.R. Kang, E.Y. Moon, Y.J. Jeon, S.K. Park and H.M. Kim, Estrogen receptor-independent inhibition of tumor necrosis factor-alpha gene expression by phytoestrogen equol is mediated by blocking nuclear factor-kappaB activation in mouse macrophages, Biochem Pharmacol 71 (2005), 136-143.
17. K. Kawabata, A. Murakami and H. Ohigashi, Citrus auraptene targets translation of MMP-7 (matrilysin) via ERK1/2-dependent and mTOR-independent mechanism, FEBS Lett 580 (2006), 5288-5294.
18. K. Kawabata, A. Murakami and H. Ohigashi, Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells, Biosci Biotechnol Biochem 69 (2005), 307-314.
19. K. Kawaguchi, H. Maruyama, T. Kometani and Y. Kumazawa, Suppression of collagen-induced arthritis by oral administration of the citrus flavonoid hesperidin, Planta Med 72 (2006), 477-479.
20. K. Kawaguchi, H. Maruyama, T. Kometani and Y. Kumazawa, Suppression of collagen-induced arthritis by oral administration of the citrus flavonoid hesperidin, Planta Med 72 (2006), 477-479.
21. S. Kawaii, Y. Tomono, E. Katase, K. Ogawa and M. Yano, HL-60 differentiating activity and flavonoid content of the readily extractable fraction prepared from citrus juice, J Agric Food Chem 47 (1999), 128-135.
22. S. Kawaii, Y. Tomono, E. Katase, K. Ogawa and Y. Yano, Antiproliferative activity of flavonoids on several cancer cell lines, Biosci Biotechnol Biochem 63 (1999), 896-869.
23. H. Kohno, S. Yoshitani, Y. Tsukio, A. Murakami, K. Koshimizu, M. Yano, H. Tokuda, H. Nishino, H. Ohigashi and T. Tanaka, Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats, Life Sci 69 (2001), 901-913.
24. S.V. Kyosseva, Mitogen-activated protein kinase signaling. Int Rev Neurobiol 59 (2004), 201-220.
25. S. Mannisto, S.A. Smith-Warner, D. Spiegelman, D. Albanes, K. Anderson, P.A. van den Brandt, J. R. Cerhan, G. Colditz, D. Feskanich, J.L. Freudenheim, E. Giovannucci, R.A. Goldbohm, S. Graham, A.B. Miller, T.E. Rohan, J. Virtamo, W.C. Willett and D.J. Hunter, Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies, Cancer Epidemiol Biomarkers Prev 13 (2004), 40-48.
26. M. Matsumoto, T. Sudo, T. Saito, H. Osada and M. Tsujimoto, Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL), J Biol Chem 275 (2000), 31155-31161.
27. Y. Miyata, T. Sato, M. Yano and A. Ito, Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin, Mol Cancer Ther 3 (2004), 839-847.
28. M.J. Moro Alvarez and M. Diaz-Curiel, Pharmacological treatment of osteoporosis for people over 70, Aging Clin Exp Res 19 (2007), 246-254.
29. A. Murakami and H. Ohigashi, Cancer-preventive anti-oxidants that attenuate free radical generation by inflammatory cells, Biol Chem 387 (2006), 387-392.
30. A. Murakami, K. Koshimizu, H. Ohigashi, S. Kuwahara, W. Kuki, Y. Takahashi, K. Hosotani, S. Kawahara and Y. Matsuoka, Characteristic rat tissue accumulation of nobiletin, a chemopreventive polymethoxyflavonoid, in comparison with luteolin, Biofactors 16 (2002), 73-82.
31. A. Murakami, M. Miyamoto and H. Ohigashi, Zerumbone, an anti-inflammatory phytochemical, induces expression of proinflammatory cytokine genes in human colon adenocarcinoma cell lines, Biofactors 21 (2004), 95-101.
32. A. Murakami, M. Song and H. Ohigashi, Phenethyl isothiocyanate suppresses receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis by blocking activation of ERK1/2 and p38 MAPK in RAW264.7 macrophages, Biofactors 30 (2007), 1-11.
33. A. Murakami, M. Takahashi, S. Jiwajinda, K. Koshimizu and H. Ohigashi, Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation, Biosci Biotechnol Biochem 63 (1999), 1811-1812.
34. A. Murakami, S. Ohura, Y. Nakamura, K. Koshimizu and H. Ohigashi, 1′-Acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in ICR mouse skin, Oncology 53 (1996), 386-391.
35. A. Murakami, T. Shigemori and H. Ohigashi, Zingiberaceous and citrus constituents, 1′-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 murine macrophages through different modes of action, J Nutr 135(12 Suppl) (2005), 2987S-2992S.
36. A. Murakami, W. Kuki, Y. Takahashi, H. Yonei, Y. Nakamura, Y. Ohto, H. Ohigashi and K. Koshimizu, Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes, Jpn J Cancer Res 88 (1997), 443-452.
37. A. Murakami, Y. Nakamura, K. Torikai, T. Tanaka, T. Koshiba, K. Koshimizu, S. Kuwahara, Y. Takahashi, K. Ogawa, M. Yano, H. Tokuda, H. Nishino, Y. Mimaki, Y. Sashida, S. Kitanaka and H. Ohigashi, Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice, Cancer Res 60 (2000), 5059-5066.
38. A. Murakami, Y. Nakamura, Y. Ohto, M. Yano, T. Koshiba, K. Koshimizu, H. Tokuda, H. Nishino and H. Ohigashi, Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid, Biofactors 12 (2000), 187-192.
39. A. Nakajima, T. Yamakuni, K. Matsuzaki, N. Nakata, H. Onozuka, A. Yokosuka, Y. Sashida, Y. Mimaki and Y. Ohizumi, Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling, J Pharmacol Exp Ther 321 (2007), 784-790.
40. S.M. Poulose, E.D. Harris and B.S. Patil, Citrus limonoids induce apoptosis in human neuroblastoma cells and have radical scavenging activity, J Nutr 135 (2005), 870-877.
41. C. Puel, J. Mathey, A. Agalias, S. Kati-Coulibaly, J. Mardon, C. Obled, M.J. Davicco, P. Lebecque, M.N. Horcajada, A.L. Skaltsounis and V. Coxam, Dose-response study of effect of oleuropein, an olive oil polyphenol, in an ovariectomy/ inflammation experimental model of bone loss in the rat, Clin Nutr 25 (2006), 859-868.
42. P.G. Reeves, F.H. Nielsen and G.C. Fahey Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J Nutr 123 (1993), 1939-1951.
43. E. Romas, M.T. Gillespie and T.J. Martin, Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis, Bone 30 (2002), 340-346.
44. G. Schett, Cells of the synovium in rheumatoid arthritis. Osteoclasts, Arthritis Res Ther 9 (2007), 203.
45. S.A. Schwartz, A. Hernandez and B. Mark Evers, The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies, Surg Oncol 8 (1999), 143-153.
46. K.D. Setchell, N.M. Brown and E. Lydeking-Olsen, The clinical importance of the metabolite equol- aclue to the effectiveness of soy and its isoflavonoids, J Nutr 132 (2002), 3577-3584.
47. D.O. Stram, J.M. Yuan, K. K. Chan, Y.T. Gao, R.K. Ross and M.C. Yu, Beta-cryptoxanthin and lung cancer in shanghai, china-an examination of potential confounding with cigarette smoking using urinary cotinine as a biomarker for true tobacco exposure, Nutr Cancer 57 (2007), 123-129.
48. M. Sugiura, M. Kakamura, K. Ogawa, Y. Ikoma, F. Ando and M. Yano, Bone mineral density in post-menopausal female subjects is associated with serum antioxidant carotenoids, Oseteoporos Int (in press).
49. R. Suzuki, H. Kohno, A. Murakami, K. Koshimizu, H. Ohigashi, M. Yano, H. Tokuda, H. Nishino and T. Tanaka, Citrus nobiletin inhibits azoxymethane-induced large bowel carcinogenesis in rats, Biofactors 22 (2004), 111-114.
50. M. Suzuki, M. Suzuki, K. Uetsuka, J. Shinozuka, H. Nakayama and K. Doi, Changes in location and number of tartrate-resistant acid phosphatase (TRAP)-positive cells during the development of type II collagen-induced arthritis in DBA/1J mice, Exp Anim 47 (1998), 211-214.
51. S. Tanaka, T. Sato, N. Akimoto, M. Yano and A. Ito, Prevention of UVB-induced photoinflammation and photoaging by a polymethoxy flavonoid, nobiletin, in human keratinocytes in vivo and in vitro, Biochem Pharmacol 68 (2004), 433-439.
52. N. Udagawa, S. Kotake, N. Kamatani, N. Takahashi and T. Suda, The molecular mechanism of osteoclastogenesis in rheumatoid arthritis, Arthritis Res 4 (2002), 281-289.
53. T.J. van Berkel, R. Out, M. Hoekstra, J. Kuiper, E. Biessen and M. van Eck, Scavenger receptors: friend or foe in atherosclerosis? Curr Opin Lipidol 16 (2005), 525-535.
54. E.F. Wagner and R. Eferl, Fos/AP-1 proteins in bone and the immune system, Immunol Rev 208 (2005), 126-140.
55. C. Wang, J.H. Steer, D.A. Joyce, K.H. Yip, M.H. Zheng and J. Xu, 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation, J Bone Miner Res 18 (2003), 2159-2168.
56. S.C. Whitman, E.M. Kurowska, J.A. Manthey and A. Daugherty, Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophages, Atherosclerosis 178 (2005), 25-32.
57. C. Xu, X. Yuan, Z. Pan, G. Shen, J.H. Kim, S. Yu, T.O. Khor, W. Li, J. Ma and A.N. Kong, Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2, Mol Cancer Ther 5 (2006), 1918-1926.